missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human BIN2 (aa 286-366) Control Fragment Recombinant Protein
Description
Highest antigen sequence indentity to the following orthologs: Mouse (47%), Rat (47%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-58487 (PA5-58487. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
BAR proteins, which are characterized by a common N-terminal BAR domain, are a family of adaptor proteins implicated in a diverse set of cellular processes. BIN1 (bridging integrator 1) and BIN2 are BAR proteins. The human BIN2 gene is located at chromosome 4q22.1, and encodes a 565-amino acid protein with a predicted molecular weight of ∽62 kDa. It shows preferential expression in hematopoietic tissues, with highest mRNA levels in spleen and peripheral blood leukocytes and also high levels in thymus, colon, and placenta. BIN2 has been shown to migrate with an apparent mobility of ∽80 kDa, and interact with BIN1.
Specifications
Specifications
| Accession Number | Q9UBW5 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 51411 |
| Name | Human BIN2 (aa 286-366) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | BIN2; BRAP1; BRAP-1; breast cancer associated protein BRAP1; breast cancer-associated protein 1; Bridging integrator 2; bridging integrator-2 |
| Common Name | BIN2 |
| Show More |